Healthcare -
Biotechnology - NASDAQ - US
$ 0.5951
2.04 %
$ 174 M
Market Cap
-0.75
P/E
LYEL - SHORT-TERM DEBT
Short-term Debt LYEL - Lyell Immunopharma, Inc.
6.27 M
LAST VALUE
131.65%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR